Evidence map›Paper›PMID 29524047›Full record

ArticleThe AAPS journal2018

Structure and Inhibitor Specificity of L,D-Transpeptidase (LdtMt2) from Mycobacterium tuberculosis and Antibiotic Resistance: Calcium Binding Promotes Dimer Formation.

Kuppan Gokulan, Sangeeta Khare, Carl E Cerniglia, Steven L Foley, Kottayil I Varughese

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Outer Membrane-Peptidoglycan Anchoring inJournal of the American Chemical Society · 2026
    Article
  2. Article
  3. Activity Profiling of Mycobacterial L,D-Transpeptidases.bioRxiv : the preprint server for biology · 2026
    Article
  4. Peptidoglycan LD-Transpeptidases.Antibiotics (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kuppan GokulanDivision of Microbiology, National Center for Toxicological Research, US-FDA, 3900 NCTR Road, Jefferson, Arkansas, 72079, USA. Kuppan.Gokulan@fda.hhs.gov.
Sangeeta KhareDivision of Microbiology, National Center for Toxicological Research, US-FDA, 3900 NCTR Road, Jefferson, Arkansas, 72079, USA.
Carl E CernigliaDivision of Microbiology, National Center for Toxicological Research, US-FDA, 3900 NCTR Road, Jefferson, Arkansas, 72079, USA.
Steven L FoleyDivision of Microbiology, National Center for Toxicological Research, US-FDA, 3900 NCTR Road, Jefferson, Arkansas, 72079, USA.
Kottayil I VarugheseDepartment of Physiology & Biophysics, University of Arkansas for Medical Sciences, #750, 4301 W. Markham St, Little Rock, Arkansas, 72205-7199, USA. KIVarughese@uams.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The final step of peptidoglycan (PG) synthesis in all bacteria is the formation of cross-linkage between PG-stems. The cross-linking between amino acids in different PG chains gives the peptidoglycan cell wall a 3-dimensional structure and adds strength and rigidity to it. There are two distinct types of cross-linkages in bacterial cell walls. D,D-transpeptidase (D,D-TPs) generate the classical 4➔3 cross-linkages and the L,D-transpeptidase (L,D-TPs) generate the 3➔3 non-classical peptide cross-linkages. The present study is aimed at understanding the nature of drug resistance associated with L,D-TP and gaining insights for designing novel antibiotics against multi-drug resistant bacteria. Penicillin and cephalosporin classes of β-lactams cannot inhibit L,D-TP function; however, carbapenems inactivate its function. We analyzed the structure of L,D-TP of Mycobacterium tuberculosis in the apo form and in complex with meropenem and imipenem. The periplasmic region of L,D-TP folds into three domains. The catalytic residues are situated in the C-terminal domain. The acylation reaction occurs between carbapenem antibiotics and the catalytic Cys-354 forming a covalent complex. This adduct formation mimics the acylation of L,D-TP with the donor PG-stem. A novel aspect of this study is that in the crystal structures of the apo and the carbapenem complexes, the N-terminal domain has a muropeptide unit non-covalently bound to it. Another interesting observation is that the calcium complex crystallized as a dimer through head and tail interactions between the monomers.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial ProteinsCalciumCatalytic DomainCrystallography, X-RayImipenemMeropenemMycobacterium tuberculosisPeptidoglycanPeptidyl TransferasesProtein BindingProtein MultimerizationRecombinant ProteinsStructure-Activity RelationshipAnti-Bacterial AgentsBacterial ProteinsCalciumImipenemMeropenemPeptidoglycanPeptidyl TransferasesRecombinant ProteinsD,D-transpeptidaseimipenemL,D-transpeptidasemeropenemβ-lactamase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.